These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10898738)

  • 21. Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT1A and V2 receptors.
    Klingler C; Ancellin N; Barrault MB; Morel A; Buhler JM; Elalouf JM; Clauser E; Lugnier C; Corman B
    Cell Signal; 1998 Jan; 10(1):65-74. PubMed ID: 9502119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A; Granot Y; Isakov N
    J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells.
    Horie K; Itoh H; Tsujimoto G
    Mol Pharmacol; 1995 Sep; 48(3):392-400. PubMed ID: 7565618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of alpha-transducin in Chinese hamster ovary cells stably transfected with the human delta-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation.
    Rubenzik M; Varga E; Stropova D; Roeske WR; Yamamura HI
    Mol Pharmacol; 2001 Nov; 60(5):1076-82. PubMed ID: 11641436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-peptide increases the expression of vasopressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathway.
    Maestroni A; Ruggieri D; Dell'Antonio G; Luzi L; Zerbini G
    Eur J Endocrinol; 2005 Jan; 152(1):135-41. PubMed ID: 15762197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.
    Pinto CS; Reif GA; Nivens E; White C; Wallace DP
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1412-24. PubMed ID: 22952279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of adenylyl cyclases in cultured human granulosa cells.
    Asbóth G; Price SA; Bellinger J; Ledger W; Barlow DH; Bernal AL
    Reproduction; 2001 Feb; 121(2):217-28. PubMed ID: 11226046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.
    Thibonnier M; Preston JA; Dulin N; Wilkins PL; Berti-Mattera LN; Mattera R
    Endocrinology; 1997 Oct; 138(10):4109-22. PubMed ID: 9322919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of ANP-C receptor signaling by arginine-vasopressin in A-10 vascular smooth muscle cells: role of protein kinase C.
    Boumati M; Li Y; Anand-Srivastava MB
    Arch Biochem Biophys; 2003 Jul; 415(2):193-202. PubMed ID: 12831842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenylyl cyclase isoforms and signal integration in models of vascular smooth muscle cells.
    Webb JG; Yates PW; Yang Q; Mukhin YV; Lanier SM
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1545-52. PubMed ID: 11557542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressin.
    Jeffries O; McGahon MK; Bankhead P; Lozano MM; Scholfield CN; Curtis TM; McGeown JG
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1591-8. PubMed ID: 19959643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway.
    O'Connor PM; Cowley AW
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F526-32. PubMed ID: 17507604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear localization signal sequence is required for VACM-1/CUL5-dependent regulation of cellular growth.
    Willis AN; Dean SE; Habbouche JA; Kempers BT; Ludwig ML; Sayfie AD; Lewis SP; Harrier S; DeBruine ZJ; Garrett R; Burnatowska-Hledin MA
    Cell Tissue Res; 2017 Apr; 368(1):105-114. PubMed ID: 27834018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene.
    Burnatowska-Hledin MA; Kossoris JB; Van Dort CJ; Shearer RL; Zhao P; Murrey DA; Abbott JL; Kan CE; Barney CC
    Biochem Biophys Res Commun; 2004 Jul; 319(3):817-25. PubMed ID: 15184056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desensitization of vasopressin sensitive adenylate cyclase by vasopressin and phorbol esters.
    Aiyar N; Nambi P; Crooke ST
    Cell Signal; 1990; 2(2):153-60. PubMed ID: 2169286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological exposure to melatonin supersensitizes the cyclic adenosine 3',5'-monophosphate-dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor.
    Witt-Enderby PA; Masana MI; Dubocovich ML
    Endocrinology; 1998 Jul; 139(7):3064-71. PubMed ID: 9645677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
    Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
    Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrations.
    Johnson AE; Le IP; Andresen BT; Stodola J; Dewey GL; Dean SB; Resau J; Haak P; Ruch T; Sartor A; Lazdins I; Barney CC; Burnatowska-Hledin MA
    Cell Tissue Res; 2012 Aug; 349(2):527-39. PubMed ID: 22581383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calmodulin regulation of cellular cyclic AMP production in response to arginine vasopressin, prostaglandin E2 and forskolin in rat renal papillary collecting tubule cells in culture.
    Ishikawa S; Saito T; Kuzuya T
    J Endocrinol; 1985 Oct; 107(1):15-22. PubMed ID: 2995530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.